Form 13-F position report

* NEUROCRINE BIOSCIENCES INC

Reported by Vestal Point Capital LP

NBIX CUSIP 64125C109 Manager CIK 0001974915

Reported 2,500,000 shares, up 620,000 (33.0%) from the prior quarter.

Reported value 11.9%; share count 33.0% vs. the prior quarter.

Added
% of reported 13F value 9.16% This manager · Q3 2026
Shares 2,500,000 Quarter-end amount reported
Reported value $354,600,000 Fair value at quarter end
Consecutive quarters held 3 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-12-31 105408000
2024-03-31 97923200
2024-06-30 0
2025-06-30 3770700
2025-09-30 0
2026-03-31 164675000
2026-06-30 316845800
2026-09-30 354600000

Quarterly position history

How this manager's reported quarter-end position changed over time.

8 quarters
Quarterly reported position history for * NEUROCRINE BIOSCIENCES INC held by Vestal Point Capital LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 2,500,000 +620,000 (33.0%) 9.16% $354,600,000 2026-11-16
Q2 2026 Added 1,880,000 +630,000 (50.4%) 7.4% $316,845,800 2026-08-14
Q1 2026 New 1,250,000 +1,250,000 (0.0%) 4.6% $164,675,000 2026-05-15
Q3 2025 Reduced 0 -30,000 (-100.0%) 0 $0 2025-11-14
Q2 2025 New 30,000 +30,000 (0.0%) 0.2% $3,770,700 2025-08-14
Q2 2024 Reduced 0 -710,000 (-100.0%) 0 $0 2024-08-14
Q1 2024 Reduced 710,000 -90,000 (-11.3%) 8.1% $97,923,200 2024-05-14
Q4 2023 New 800,000 +800,000 (0.0%) 11.17% $105,408,000 2024-02-13

Who else reported the position

877 managers reported * NEUROCRINE BIOSCIENCES INC for Q3 2026.

Managers reporting * NEUROCRINE BIOSCIENCES INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 14,856,103 +1,144,496 0.03% $2,107,189,670 9 qtrs
Dodge & Cox Reduced 5,504,578 -80,129 0.42% $780,769,344 13 qtrs
JPMorgan Chase & Co Reduced 5,292,589 -1,106,085 0.04% $733,010,216 48 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 5,060,036 +85,953 0.03% $717,715,506 3 qtrs
STATE STREET CORPORATION Added 4,807,975 +422,377 0.02% $681,963,174 54 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 4,580,803 +35,464 0.01% $649,741,098 3 qtrs
AQR CAPITAL MANAGEMENT LLC Reduced 3,062,385 -755,652 0.13% $422,547,761 35 qtrs
Vestal Point Capital LP This report Added 2,500,000 +620,000 9.16% $354,600,000 3 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 2,300,697 -35,200 0.44% $326,330,862 32 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 2,127,482 -11,295 0.02% $301,038,376 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
2,500,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.